Drug Profile
Research programme: connective tissue regeneration therapies - Bio3 Research
Alternative Names: CTR-1; CTR-2; CTR-3; CTR-4Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Bio3 Research
- Class
- Mechanism of Action Protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bone disorders; Cartilage disorders; Musculoskeletal disorders; Wounds
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bone-disorders in Italy
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cartilage-disorders in Italy
- 04 Nov 2017 No recent reports of development identified for preclinical development in Musculoskeletal-disorders in Italy